Practice Guideline
doi: 10.1007/s00520-010-0920-z.
Epub 2010 May 26.
Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement
Affiliations
- PMID: 20505956
- DOI: 10.1007/s00520-010-0920-z
Item in Clipboard
Practice Guideline
Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement
Support Care Cancer.
2011 Mar.
Abstract
This paper will evaluate various topics related to chemotherapy-induced nausea and vomiting. The results published reflect a consensus conference convened in Perugia, Italy. The topics discussed include antiemetic therapy of multiple-day chemotherapy, high-dose chemotherapy, and rescue antiemetics.
Comment in
-
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant.Support Care Cancer. 2012 May;20(5):891-2. doi: 10.1007/s00520-012-1411-1. Epub 2012 Feb 19. Support Care Cancer. 2012. PMID: 22350646 No abstract available.
Similar articles
-
Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement.Support Care Cancer. 2005 Feb;13(2):112-6. doi: 10.1007/s00520-004-0704-4. Epub 2004 Oct 9. Support Care Cancer. 2005. PMID: 15480812 Review.
-
Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.Cancer Med. 2015 Mar;4(3):333-41. doi: 10.1002/cam4.373. Epub 2014 Dec 23. Cancer Med. 2015. PMID: 25533447 Free PMC article. Clinical Trial.
-
Delayed emesis: moderately emetogenic chemotherapy (single-day chemotherapy regimens only).Support Care Cancer. 2011 Mar;19 Suppl 1:S57-62. doi: 10.1007/s00520-010-1039-y. Epub 2010 Dec 5. Support Care Cancer. 2011. PMID: 21132332
-
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting.N Engl J Med. 2016 Apr 7;374(14):1356-67. doi: 10.1056/NEJMra1515442. N Engl J Med. 2016. PMID: 27050207 Review. No abstract available.
-
Addition of Aprepitant (Emend®) to Standard Antiemetic Regimen Continued for 7 Days after Chemotherapy for Stem Cell Transplantation Provides Significant Reduction of Vomiting.Oncology. 2015;89(1):31-6. doi: 10.1159/000371523. Epub 2015 Feb 4. Oncology. 2015. PMID: 25659986 Clinical Trial.
Cited by
-
Response.Support Care Cancer. 2015 Aug;23(8):2213. doi: 10.1007/s00520-015-2753-2. Epub 2015 May 15. Support Care Cancer. 2015. PMID: 25975674 No abstract available.
-
Safety and pharmacokinetic evaluation of repeated intravenous administration of palonosetron 0.75 mg in patients receiving highly or moderately emetogenic chemotherapy.Support Care Cancer. 2014 Jul;22(7):1959-64. doi: 10.1007/s00520-014-2179-2. Epub 2014 Mar 4. Support Care Cancer. 2014. PMID: 24590375
-
Results of a 7-day aprepitant schedule for the prevention of nausea and vomiting in 5-day cisplatin-based germ cell tumor chemotherapy.Support Care Cancer. 2013 Jun;21(6):1561-8. doi: 10.1007/s00520-012-1696-0. Epub 2012 Dec 30. Support Care Cancer. 2013. PMID: 23274926 Clinical Trial.
-
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.Support Care Cancer. 2016 Jul;24(7):2837-42. doi: 10.1007/s00520-016-3100-y. Epub 2016 Feb 2. Support Care Cancer. 2016. PMID: 26838019 Clinical Trial.
-
A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study).EClinicalMedicine. 2022 Dec 15;55:101771. doi: 10.1016/j.eclinm.2022.101771. eCollection 2023 Jan. EClinicalMedicine. 2022. PMID: 36712888 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
